Tyler Seibert

Title(s)Assistant Professor In Residence, Radiation Medicine and Applied Science
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
ORCID ORCID Icon0000-0002-4089-7399 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California Berkeley, Berkeley, CABS12/2005Bioengineering
    University of California San Diego, La Jolla, CAPhD06/2011Bioengineering
    University of California San Diego, La Jolla, CAMD06/2013Medicine
    Scripps Mercy Hospital, San Diego, CAResidency06/2014Medicine
    University of California San Diego, La Jolla, CAResidency06/2018Radiation Oncology
    Collapse Awards and Honors
    American Society for Radiation Oncology / Prostate Cancer Foundation2021  - 2023Prostate Cancer Foundation Young Investigator Award
    Radiological Society of North America2018Roentgen Resident Research Award
    American Board of Radiology2015  - 2018Holman Pathway research fellow
    UC San Diego Radiation Oncology2015Resident of the Year
    Scripps Mercy Hospital2014Jack Geller Research Award
    1999National Merit Scholar
    National Institutes of Health2006  - 2013NIH Medical Scientist Training Program

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Improving assessment of prostate cancer bone metastases using advanced diffusion imaging
    NIH K08EB026503Jul 1, 2019 - Jun 30, 2023
    Role: Principal Investigator
    Whole-Body RSI-MRI as an Indicator for Radiation Therapy Response of Metastatic Prostate Cancer
    U.S. Department of Defense PC160673Jun 1, 2017 - May 30, 2020
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Faculty Mentoring

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial. JAMA. 2024 Apr 06. Martin RM, Turner EL, Young GJ, Metcalfe C, Walsh EI, Lane JA, Sterne JAC, Noble S, Holding P, Ben-Shlomo Y, Williams NJ, Pashayan N, Bui MN, Albertsen PC, Seibert TM, Zietman AL, Oxley J, Adolfsson J, Mason MD, Davey Smith G, Neal DE, Hamdy FC, Donovan JL, CAP Trial Group. PMID: 38581198; PMCID: PMC10999004.
      View in: PubMed   Mentions:
    2. An accessible deep learning tool for voxel-wise classification of brain malignancies from perfusion MRI. Cell Rep Med. 2024 Mar 05; 101464. Garcia-Ruiz A, Pons-Escoda A, Grussu F, Naval-Baudin P, Monreal-Aguero C, Hermann G, Karunamuni R, Ligero M, Lopez-Rueda A, Oleaga L, Berbís MÁ, Cabrera-Zubizarreta A, Martin-Noguerol T, Luna A, Seibert TM, Majos C, Perez-Lopez R. PMID: 38471504.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Adrenal-Permissive Germline HSD3B1 Allele and Prostate Cancer Outcomes. JAMA Netw Open. 2024 Mar 04; 7(3):e242976. McKay RR, Nelson TJ, Pagadala MS, Teerlink CC, Gao A, Bryant AK, Agiri FY, Guram K, Thompson RF, Pridgen KM, Seibert TM, Lee KM, Carter H, Lynch JA, Hauger RL, Rose BS. PMID: 38506808; PMCID: PMC10955379.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. Quantitative MRI biomarker for classification of clinically significant prostate cancer: calibration for reproducibility across echo times. medRxiv. 2024 Jan 26. Kallis K, Conlin CC, Ollison C, Hahn ME, Rakow-Penner R, Dale AM, Seibert TM. PMID: 38343810; PMCID: PMC10854339.
      View in: PubMed   Mentions:
    5. Focal radiotherapy boost to MR-visible tumor for prostate cancer: a systematic review. World J Urol. 2024 Jan 20; 42(1):56. Dornisch AM, Zhong AY, Poon DMC, Tree AC, Seibert TM. PMID: 38244059; PMCID: PMC10799816.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Genetic risk and likelihood of prostate cancer detection on first biopsy by ancestry. J Natl Cancer Inst. 2024 Jan 11. Lee KM, Nelson T, Bryant A, Teerlink C, Gulati R, Pagadala M, Tcheandjieu C, Pridgen KM, DuVall SL, Yamoah K, Vassy JL, Seibert TM, Hauger R, Rose BS, Lynch JA. PMID: 38212986.
      View in: PubMed   Mentions:    Fields:    
    7. Predictability of Olfactory Neuroblastoma Staging Systems. JAMA Otolaryngol Head Neck Surg. 2024 Jan 01; 150(1):84-85. Sun R, Seibert TM, Wei LJ. PMID: 37971764.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Identification of Novel Loci and Cross-Disorder Pleiotropy Through Multi-Ancestry Genome-Wide Analysis of Alcohol Use Disorder in Over One Million Individuals. Res Sq. 2023 Dec 22. Icick R, Shadrin A, Holen B, Karadag N, Parker N, O'Connell K, Frei O, Bahrami S, Høegh M, Lagerberg T, Cheng W, Seibert T, Djurovic S, Dale A, Zhou H, Edenberg H, Gelernter J, Smeland O, Hindley G, Andreassen O. PMID: 38196616; PMCID: PMC10775504.
      View in: PubMed   Mentions:
    9. Use of focal radiotherapy boost for prostate cancer: radiation oncologists' perspectives and perceived barriers to implementation. Radiat Oncol. 2023 Nov 11; 18(1):188. Zhong AY, Lui AJ, Katz MS, Berlin A, Kamran SC, Kishan AU, Murthy V, Nagar H, Seible D, Stish BJ, Tree AC, Seibert TM. PMID: 37950310; PMCID: PMC10638743.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. Restriction spectrum imaging with elastic image registration for automated evaluation of response to neoadjuvant therapy in breast cancer. Front Oncol. 2023; 13:1237720. Andreassen MMS, Loubrie S, Tong MW, Fang L, Seibert TM, Wallace AM, Zare S, Ojeda-Fournier H, Kuperman J, Hahn M, Jerome NP, Bathen TF, Rodríguez-Soto AE, Dale AM, Rakow-Penner R. PMID: 37781199; PMCID: PMC10541212.
      View in: PubMed   Mentions:
    11. Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer. BJUI Compass. 2024 Jan; 5(1):142-149. Leapman MS, Sutherland R, Gross CP, Ma X, Seibert TM, Cooperberg MR, Catalona WJ, Loeb S, Schulman-Green D. PMID: 38179031; PMCID: PMC10764160.
      View in: PubMed   Mentions:
    12. ReIGNITE Radiation Therapy Boost: A Prospective, International Study of Radiation Oncologists' Accuracy in Contouring Prostate Tumors for Focal Radiation Therapy Boost on Conventional Magnetic Resonance Imaging Alone or With Assistance of Restriction Spectrum Imaging. Int J Radiat Oncol Biol Phys. 2023 Dec 01; 117(5):1145-1152. Lui AJ, Kallis K, Zhong AY, Hussain TS, Conlin C, Digma LA, Phan N, Mathews IT, Do DD, Domingo MR, Karunamuni R, Kuperman J, Dale AM, Shabaik A, Rakow-Penner R, Hahn ME, Seibert TM. PMID: 37453559.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    13. Agent Orange exposure and prostate cancer risk in the Million Veteran Program. medRxiv. 2023 Jun 16. Lui AJ, Pagadala MS, Zhong AY, Lynch J, Karunamuni R, Lee KM, Plym A, Rose BS, Carter H, Kibel AS, DuVall SL, Gaziano JM, Panizzon MS, Hauger RL, Seibert TM. PMID: 37398205; PMCID: PMC10312838.
      View in: PubMed   Mentions:
    14. Use of focal radiotherapy boost for prostate cancer and perceived barriers toward its implementation: a survey. medRxiv. 2023 Jun 08. Zhong AY, Lui AJ, Katz MS, Berlin A, Kamran SC, Kishan AU, Murthy V, Nagar H, Seible D, Stish BJ, Tree AC, Seibert TM. PMID: 37333345; PMCID: PMC10274968.
      View in: PubMed   Mentions:
    15. Dose-Dependent Atrophy in Bilateral Amygdalae and Nuclei After Brain Radiation Therapy and Its Association With Mood and Memory Outcomes on a Longitudinal Clinical Trial. Int J Radiat Oncol Biol Phys. 2023 Nov 15; 117(4):834-845. Unnikrishnan S, Karunamuni R, Salans MA, Gudipati S, Qian AS, Yu J, Connor M, Huynh-Le MP, Tibbs MD, Hermann G, Reyes A, Stasenko A, Seibert TM, McDonald CR, Hattangadi-Gluth JA. PMID: 37230430.
      View in: PubMed   Mentions: 2     Fields:    
    16. Improved multimodal prediction of progression from MCI to Alzheimer's disease combining genetics with quantitative brain MRI and cognitive measures. Alzheimers Dement. 2023 11; 19(11):5151-5158. Reas ET, Shadrin A, Frei O, Motazedi E, McEvoy L, Bahrami S, van der Meer D, Makowski C, Loughnan R, Wang X, Broce I, Banks SJ, Fominykh V, Cheng W, Holland D, Smeland OB, Seibert T, Selbaek G, Brewer JB, Fan CC, Andreassen OA, Dale AM, Alzheimer's Disease Neuroimaging Initiative. PMID: 37132098; PMCID: PMC10620101.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Response to Haiman, Kote-Jarai, Darst et al. J Natl Cancer Inst. 2023 03 09; 115(3):343-344. Seibert TM, Pagadala MS, Lynch J, Karunamuni R, Carter H, Rose BS, Hauger RL. PMID: 36629482; PMCID: PMC9996213.
      View in: PubMed   Mentions:    Fields:    
    18. NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023. J Natl Compr Canc Netw. 2023 03; 21(3):236-246. Moses KA, Sprenkle PC, Bahler C, Box G, Carlsson SV, Catalona WJ, Dahl DM, Dall'Era M, Davis JW, Drake BF, Epstein JI, Etzioni RB, Farrington TA, Garraway IP, Jarrard D, Kauffman E, Kaye D, Kibel AS, LaGrange CA, Maroni P, Ponsky L, Reys B, Salami SS, Sanchez A, Seibert TM, Shaneyfelt TM, Smaldone MC, Sonn G, Tyson MD, Vapiwala N, Wake R, Washington S, Yu A, Yuh B, Berardi RA, Freedman-Cass DA. PMID: 36898362.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    19. Comparison of synthesized and acquired high b -value diffusion-weighted MRI for detection of prostate cancer. medRxiv. 2023 Feb 18. Kallis K, Conlin CC, Zhong AY, Hussain TS, Chatterjee A, Karczmar GS, Rakow-Penner R, Dale A, Seibert T. PMID: 36824958; PMCID: PMC9949172.
      View in: PubMed   Mentions:
    20. The relationship between radiation dose and bevacizumab-related imaging abnormality in patients with brain tumors: A voxel-wise normal tissue complication probability (NTCP) analysis. PLoS One. 2023; 18(2):e0279812. Salans M, Houri J, Karunamuni R, Hopper A, Delfanti R, Seibert TM, Bahrami N, Sharifzadeh Y, McDonald C, Dale A, Moiseenko V, Farid N, Hattangadi-Gluth JA. PMID: 36800342; PMCID: PMC9937457.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation. J Urol. 2023 04; 209(4):710-718. Leapman MS, Wang R, Loeb S, Seibert TM, Gaylis FD, Lowentritt B, Brown GA, Chen R, Lin D, Witte J, Cooperberg MR, Catalona WJ, Gross CP, Ma X. PMID: 36753746.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program. J Natl Cancer Inst. 2023 02 08; 115(2):190-199. Pagadala MS, Lynch J, Karunamuni R, Alba PR, Lee KM, Agiri FY, Anglin T, Carter H, Gaziano JM, Jasuja GK, Deka R, Rose BS, Panizzon MS, Hauger RL, Seibert TM. PMID: 36305680; PMCID: PMC9905969.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    23. Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention. Eur Urol. 2023 03; 83(3):241-248. Seibert TM, Garraway IP, Plym A, Mahal BA, Giri V, Jacobs MF, Cheng HH, Loeb S, Helfand BT, Eeles RA, Morgan TM. PMID: 36609003.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    24. A Multicompartmental Diffusion Model for Improved Assessment of Whole-Body Diffusion-weighted Imaging Data and Evaluation of Prostate Cancer Bone Metastases. Radiol Imaging Cancer. 2023 01; 5(1):e210115. Conlin CC, Feng CH, Digma LA, Rodríguez-Soto AE, Kuperman JM, Rakow-Penner R, Karow DS, White NS, Seibert TM, Hahn ME, Dale AM. PMID: 36705559; PMCID: PMC9896230.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Automated Patient-level Prostate Cancer Detection with Quantitative Diffusion Magnetic Resonance Imaging. Eur Urol Open Sci. 2023 Jan; 47:20-28. Zhong AY, Digma LA, Hussain T, Feng CH, Conlin CC, Tye K, Lui AJ, Andreassen MMS, Rodríguez-Soto AE, Karunamuni R, Kuperman J, Kane CJ, Rakow-Penner R, Hahn ME, Dale AM, Seibert TM. PMID: 36601040; PMCID: PMC9806706.
      View in: PubMed   Mentions: 3  
    26. PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestry. BMC Cancer. 2022 Dec 09; 22(1):1289. Pagadala MS, Linscott JA, Talwar JV, Seibert TM, Rose B, Lynch J, Panizzon M, Hauger R, Hansen MH, Sammon JD, Hayn MH, Kader K, Carter H, Ryan ST. PMID: 36494783; PMCID: PMC9733391.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    27. Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meeting. Prostate. 2023 02; 83(3):207-226. Miyahira AK, Hawley JE, Adelaiye-Ogala R, Calais J, Nappi L, Parikh R, Seibert TM, Wasmuth EV, Wei XX, Pienta KJ, Soule HR. PMID: 36443902.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Tri-Compartmental Restriction Spectrum Imaging Breast Model Distinguishes Malignant Lesions from Benign Lesions and Healthy Tissue on Diffusion-Weighted Imaging. Cancers (Basel). 2022 06 30; 14(13). Besser AH, Fang LK, Tong MW, Andreassen MMS, Ojeda-Fournier H, Conlin CC, Loubrie S, Seibert TM, Hahn ME, Kuperman JM, Wallace AM, Dale AM, Rodríguez-Soto AE, Rakow-Penner RA. PMID: 35804972; PMCID: PMC9264763.
      View in: PubMed   Mentions:
    29. Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score. Prostate Cancer Prostatic Dis. 2022 04; 25(4):755-761. Huynh-Le MP, Karunamuni R, Fan CC, Asona L, Thompson WK, Martinez ME, Eeles RA, Kote-Jarai Z, Muir KR, Lophatananon A, Schleutker J, Pashayan N, Batra J, Grönberg H, Neal DE, Nordestgaard BG, Tangen CM, MacInnis RJ, Wolk A, Albanes D, Haiman CA, Travis RC, Blot WJ, Stanford JL, Mucci LA, West CML, Nielsen SF, Kibel AS, Cussenot O, Berndt SI, Koutros S, Sørensen KD, Cybulski C, Grindedal EM, Menegaux F, Park JY, Ingles SA, Maier C, Hamilton RJ, Rosenstein BS, Lu YJ, Watya S, Vega A, Kogevinas M, Wiklund F, Penney KL, Huff CD, Teixeira MR, Multigner L, Leach RJ, Brenner H, John EM, Kaneva R, Logothetis CJ, Neuhausen SL, De Ruyck K, Ost P, Razack A, Newcomb LF, Fowke JH, Gamulin M, Abraham A, Claessens F, Castelao JE, Townsend PA, Crawford DC, Petrovics G, van Schaik RHN, Parent MÉ, Hu JJ, Zheng W, UKGPCS collaborators, APCB (Australian Prostate Cancer BioResource), NC-LA PCaP Investigators, IMPACT Study Steering Committee and Collaborators, Canary PASS Investigators, Profile Study Steering Committee, PRACTICAL Consortium, Mills IG, Andreassen OA, Dale AM, Seibert TM. PMID: 35152271; PMCID: PMC9372232.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    30. Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer. Eur Urol Open Sci. 2022 Mar; 37:113-119. Press BH, Jones T, Olawoyin O, Lokeshwar SD, Rahman SN, Khajir G, Lin DW, Cooperberg MR, Loeb S, Darst BF, Zheng Y, Chen RC, Witte JS, Seibert TM, Catalona WJ, Leapman MS, Sprenkle PC. PMID: 35243396; PMCID: PMC8883188.
      View in: PubMed   Mentions: 5  
    31. Conservative Management of Low-Risk Prostate Cancer: A Path to Value-Based Care. Urol Pract. 2022 May; 9(3):195-197. Gaylis FD, Cooperberg MR, Loeb S, Chen RC, Seibert TM, Cohen E, Dato P, Emeka AA, Prime R, Romo S, Catalona WJ. PMID: 37145554.
      View in: PubMed   Mentions:
    32. Correcting B0 inhomogeneity-induced distortions in whole-body diffusion MRI of bone. Sci Rep. 2022 01 07; 12(1):265. Digma LA, Feng CH, Conlin CC, Rodríguez-Soto AE, Zhong AY, Hussain TS, Lui AJ, Batra K, Simon AB, Karunamuni R, Kuperman J, Rakow-Penner R, Hahn ME, Dale AM, Seibert TM. PMID: 34997164; PMCID: PMC8741963.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    33. Using Polygenic Hazard Scores to Predict Age at Onset of Alzheimer's Disease in Nordic Populations. J Alzheimers Dis. 2022; 88(4):1533-1544. Motazedi E, Cheng W, Thomassen JQ, Frei O, Rongve A, Athanasiu L, Bahrami S, Shadrin A, Ulstein I, Stordal E, Brækhus A, Saltvedt I, Sando SB, O'Connell KS, Hindley G, van der Meer D, Bergh S, Nordestgaard BG, Tybjærg-Hansen A, Bråthen G, Pihlstrøm L, Djurovic S, Frikke-Schmidt R, Fladby T, Aarsland D, Selbæk G, Seibert TM, Dale AM, Fan CC, Andreassen OA. PMID: 35848024; PMCID: PMC10022308.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    34. Characterization of the diffusion signal of breast tissues using multi-exponential models. Magn Reson Med. 2022 04; 87(4):1938-1951. Rodríguez-Soto AE, Andreassen MMS, Fang LK, Conlin CC, Park HH, Ahn GS, Bartsch H, Kuperman J, Vidic I, Ojeda-Fournier H, Wallace AM, Hahn M, Seibert TM, Jerome NP, Østlie A, Bathen TF, Goa PE, Rakow-Penner R, Dale AM. PMID: 34904726; PMCID: PMC9148547.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    35. Genetic Stratification of Age-Dependent Parkinson's Disease Risk by Polygenic Hazard Score. Mov Disord. 2022 01; 37(1):62-69. Pihlstrøm L, Fan CC, Frei O, Tan M, Karunamuni RA, Blauwendraat C, Bandres-Ciga S, Gan-Or Z, Grosset DG, International Parkinson's Disease Genomics Consortium (IPDGC), Dale AM, Seibert TM, Andreassen OA. PMID: 34612543.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    36. Vertex-wise multivariate genome-wide association study identifies 780 unique genetic loci associated with cortical morphology. Neuroimage. 2021 12 01; 244:118603. Shadrin AA, Kaufmann T, van der Meer D, Palmer CE, Makowski C, Loughnan R, Jernigan TL, Seibert TM, Hagler DJ, Smeland OB, Motazedi E, Chu Y, Lin A, Cheng W, Hindley G, Thompson WK, Fan CC, Holland D, Westlye LT, Frei O, Andreassen OA, Dale AM. PMID: 34560273; PMCID: PMC8785963.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    37. Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24. Prostate Cancer Prostatic Dis. 2022 02; 25(2):229-237. Karunamuni RA, Huynh-Le MP, Fan CC, Thompson W, Lui A, Martinez ME, Rose BS, Mahal B, Eeles RA, Kote-Jarai Z, Muir K, Lophatananon A, UKGPCS Collaborators, Tangen CM, Goodman PJ, Thompson IM, Blot WJ, Zheng W, Kibel AS, Drake BF, Cussenot O, Cancel-Tassin G, Menegaux F, Truong T, Park JY, Lin HY, Taylor JA, Bensen JT, Mohler JL, Fontham ETH, Multigner L, Blanchet P, Brureau L, Romana M, Leach RJ, John EM, Fowke JH, Bush WS, Aldrich MC, Crawford DC, Cullen J, Petrovics G, Parent MÉ, Hu JJ, Sanderson M, PRACTICAL Consortium, Mills IG, Andreassen OA, Dale AM, Seibert TM. PMID: 34127801; PMCID: PMC8669040.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    38. Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. Letter. J Urol. 2021 07; 206(1):171-172. Gaylis FD, Cooperberg MR, Chen RC, Malin J, Loeb S, Witte JS, Carroll PR, Cohen ES, Dato PE, Lin DW, Zheng Y, Seibert TM, Setzler C, Wilt W, Gomez SL, Chan JML, Catalona WJ. PMID: 33818133.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Voxel-level Classification of Prostate Cancer on Magnetic Resonance Imaging: Improving Accuracy Using Four-Compartment Restriction Spectrum Imaging. J Magn Reson Imaging. 2021 09; 54(3):975-984. Feng CH, Conlin CC, Batra K, Rodríguez-Soto AE, Karunamuni R, Simon A, Kuperman J, Rakow-Penner R, Hahn ME, Dale AM, Seibert TM. PMID: 33786915; PMCID: PMC8363567.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    40. Common genetic and clinical risk factors: association with fatal prostate cancer in the Cohort of Swedish Men. Prostate Cancer Prostatic Dis. 2021 09; 24(3):845-851. Huynh-Le MP, Karunamuni R, Fan CC, Thompson WK, Muir K, Lophatananon A, Tye K, Wolk A, Håkansson N, Mills IG, Andreassen OA, Dale AM, Seibert TM, PRACTICAL Consortium. PMID: 33723363; PMCID: PMC8387332.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    41. Polygenic hazard score is associated with prostate cancer in multi-ethnic populations. Nat Commun. 2021 02 23; 12(1):1236. Huynh-Le MP, Fan CC, Karunamuni R, Thompson WK, Martinez ME, Eeles RA, Kote-Jarai Z, Muir K, Schleutker J, Pashayan N, Batra J, Grönberg H, Neal DE, Donovan JL, Hamdy FC, Martin RM, Nielsen SF, Nordestgaard BG, Wiklund F, Tangen CM, Giles GG, Wolk A, Albanes D, Travis RC, Blot WJ, Zheng W, Sanderson M, Stanford JL, Mucci LA, West CML, Kibel AS, Cussenot O, Berndt SI, Koutros S, Sørensen KD, Cybulski C, Grindedal EM, Menegaux F, Khaw KT, Park JY, Ingles SA, Maier C, Hamilton RJ, Thibodeau SN, Rosenstein BS, Lu YJ, Watya S, Vega A, Kogevinas M, Penney KL, Huff C, Teixeira MR, Multigner L, Leach RJ, Cannon-Albright L, Brenner H, John EM, Kaneva R, Logothetis CJ, Neuhausen SL, De Ruyck K, Pandha H, Razack A, Newcomb LF, Fowke JH, Gamulin M, Usmani N, Claessens F, Gago-Dominguez M, Townsend PA, Bush WS, Roobol MJ, Parent MÉ, Hu JJ, Mills IG, Andreassen OA, Dale AM, Seibert TM, UKGPCS collaborators, APCB (Australian Prostate Cancer BioResource), NC-LA PCaP Investigators, IMPACT Study Steering Committee and Collaborators, Canary PASS Investigators, Profile Study Steering Committee, PRACTICAL Consortium. PMID: 33623038; PMCID: PMC7902617.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    42. Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer. Prostate Cancer Prostatic Dis. 2021 06; 24(2):532-541. Karunamuni RA, Huynh-Le MP, Fan CC, Thompson W, Eeles RA, Kote-Jarai Z, Muir K, Lophatananon A, UKGPCS collaborators, Schleutker J, Pashayan N, Batra J, APCB BioResource (Australian Prostate Cancer BioResource), Grönberg H, Walsh EI, Turner EL, Lane A, Martin RM, Neal DE, Donovan JL, Hamdy FC, Nordestgaard BG, Tangen CM, MacInnis RJ, Wolk A, Albanes D, Haiman CA, Travis RC, Stanford JL, Mucci LA, West CML, Nielsen SF, Kibel AS, Wiklund F, Cussenot O, Berndt SI, Koutros S, Sørensen KD, Cybulski C, Grindedal EM, Park JY, Ingles SA, Maier C, Hamilton RJ, Rosenstein BS, Vega A, IMPACT Study Steering Committee and Collaborators, Kogevinas M, Penney KL, Teixeira MR, Brenner H, John EM, Kaneva R, Logothetis CJ, Neuhausen SL, Razack A, Newcomb LF, Canary PASS Investigators, Gamulin M, Usmani N, Claessens F, Gago-Dominguez M, Townsend PA, Roobol MJ, Zheng W, Profile Study Steering Committee, Mills IG, Andreassen OA, Dale AM, Seibert TM, PRACTICAL Consortium. PMID: 33420416; PMCID: PMC8157993.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    43. Discrimination of Breast Cancer from Healthy Breast Tissue Using a Three-component Diffusion-weighted MRI Model. Clin Cancer Res. 2021 02 15; 27(4):1094-1104. Andreassen MMS, Rodríguez-Soto AE, Conlin CC, Vidic I, Seibert TM, Wallace AM, Zare S, Kuperman J, Abudu B, Ahn GS, Hahn M, Jerome NP, Østlie A, Bathen TF, Ojeda-Fournier H, Goa PE, Rakow-Penner R, Dale AM. PMID: 33148675; PMCID: PMC8174004.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    44. Improved Characterization of Diffusion in Normal and Cancerous Prostate Tissue Through Optimization of Multicompartmental Signal Models. J Magn Reson Imaging. 2021 02; 53(2):628-639. Conlin CC, Feng CH, Rodriguez-Soto AE, Karunamuni RA, Kuperman JM, Holland D, Rakow-Penner R, Hahn ME, Seibert TM, Dale AM. PMID: 33131186; PMCID: PMC8178435.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    45. Automated contouring and planning pipeline for hippocampal-avoidant whole-brain radiotherapy. Radiat Oncol. 2020 Oct 30; 15(1):251. Feng CH, Cornell M, Moore KL, Karunamuni R, Seibert TM. PMID: 33126894; PMCID: PMC7602303.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    46. African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer. Int J Cancer. 2021 01 01; 148(1):99-105. Karunamuni RA, Huynh-Le MP, Fan CC, Thompson W, Eeles RA, Kote-Jarai Z, Muir K, UKGPCS Collaborators, Lophatananon A, Tangen CM, Goodman PJ, Thompson IM, Blot WJ, Zheng W, Kibel AS, Drake BF, Cussenot O, Cancel-Tassin G, Menegaux F, Truong T, Park JY, Lin HY, Bensen JT, Fontham ETH, Mohler JL, Taylor JA, Multigner L, Blanchet P, Brureau L, Romana M, Leach RJ, John EM, Fowke J, Bush WS, Aldrich M, Crawford DC, Srivastava S, Cullen JC, Petrovics G, Parent MÉ, Hu JJ, Sanderson M, Mills IG, Andreassen OA, Dale AM, Seibert TM, PRACTICAL Consortium. PMID: 32930425; PMCID: PMC8135907.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    47. A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data. Cancer Epidemiol Biomarkers Prev. 2020 09; 29(9):1731-1738. Huynh-Le MP, Fan CC, Karunamuni R, Walsh EI, Turner EL, Lane JA, Martin RM, Neal DE, Donovan JL, Hamdy FC, Parsons JK, Eeles RA, Easton DF, Kote-Jarai Z, Amin Al Olama A, Benlloch Garcia S, Muir K, Grönberg H, Wiklund F, Aly M, Schleutker J, Sipeky C, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Pharoah PDP, Pashayan N, Khaw KT, Thibodeau SN, McDonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokolorczyk D, Kluzniak W, Cannon-Albright LA, Brenner H, Schöttker B, Holleczek B, Park JY, Sellers TA, Lin HY, Slavov CK, Kaneva RP, Mitev VI, Batra J, Clements JA, Spurdle AB, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Mills IG, Andreassen OA, Dale AM, Seibert TM, Australian Prostate Cancer BioResource (APCB), PRACTICAL Consortium. PMID: 32581112; PMCID: PMC7483627.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    48. The effect of sample size on polygenic hazard models for prostate cancer. Eur J Hum Genet. 2020 10; 28(10):1467-1475. Karunamuni RA, Huynh-Le MP, Fan CC, Eeles RA, Easton DF, Kote-Jarai Z, Amin Al Olama A, Benlloch Garcia S, Muir K, Gronberg H, Wiklund F, Aly M, Schleutker J, Sipeky C, Tammela TLJ, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Thibodeau SN, McDonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokolorczyk D, Kluzniak W, Cannon-Albright L, Brenner H, Schöttker B, Holleczek B, Park JY, Sellers TA, Lin HY, Slavov C, Kaneva R, Mitev V, Batra J, Clements JA, Spurdle A, Australian Prostate Cancer BioResource (APCB), Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Mills IG, Andreassen OA, Dale AM, Seibert TM, PRACTICAL Consortium. PMID: 32514134; PMCID: PMC7608255.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    49. Reply to The 5-year relative survival of older patients with prostate cancer is insignificantly different from the 5-year survival of all men of a similar age. Cancer. 2020 06 01; 126(11):2718-2719. Huynh-Le MP, Seibert TM. PMID: 32073647.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    50. Restriction Spectrum Imaging Differentiates True Tumor Progression From Immune-Mediated Pseudoprogression: Case Report of a Patient With Glioblastoma. Front Oncol. 2020; 10:24. Daghighi S, Bahrami N, Tom WJ, Coley N, Seibert TM, Hattangadi-Gluth JA, Piccioni DE, Dale AM, Farid N, McDonald CR. PMID: 32047723; PMCID: PMC6997150.
      View in: PubMed   Mentions: 5  
    51. Age dependence of modern clinical risk groups for localized prostate cancer-A population-based study. Cancer. 2020 04 15; 126(8):1691-1699. Huynh-Le MP, Myklebust TÅ, Feng CH, Karunamuni R, Johannesen TB, Dale AM, Andreassen OA, Seibert TM. PMID: 31899813; PMCID: PMC7103486.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    52. Multi-domain neurocognitive classification of primary brain tumor patients prior to radiotherapy on a prospective clinical trial. J Neurooncol. 2020 Jan; 146(1):131-138. Karunamuni R, Tringale KR, Burkeen J, Tibbs MD, Huynh-Le MP, Bahrami N, Marshall D, Seibert TM, McDonald CR, Hattangadi-Gluth JA. PMID: 31760596; PMCID: PMC7025809.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    53. Quantitative Imaging Biomarkers of Damage to Critical Memory Regions Are Associated With Post-Radiation Therapy Memory Performance in Brain Tumor Patients. Int J Radiat Oncol Biol Phys. 2019 11 15; 105(4):773-783. Tringale KR, Nguyen TT, Karunamuni R, Seibert T, Huynh-Le MP, Connor M, Moiseenko V, Gorman MK, Marshall A, Tibbs MD, Farid N, Simpson D, Sanghvi P, McDonald CR, Hattangadi-Gluth JA. PMID: 31408667; PMCID: PMC6876859.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    54. Using a genetic risk score to calculate the optimal age for an individual to undergo coronary artery calcium screening. J Cardiovasc Comput Tomogr. 2019 Jul - Aug; 13(4):203-210. Severance LM, Contijoch FJ, Carter H, Fan CC, Seibert TM, Dale AM, McVeigh ER. PMID: 31104941; PMCID: PMC6801022.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    55. Dose-dependent atrophy of the amygdala after radiotherapy. Radiother Oncol. 2019 07; 136:44-49. Huynh-Le MP, Karunamuni R, Moiseenko V, Farid N, McDonald CR, Hattangadi-Gluth JA, Seibert TM. PMID: 31015128; PMCID: PMC7041546.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansPHPublic Health
    56. Identifying early diffusion imaging biomarkers of regional white matter injury as indicators of executive function decline following brain radiotherapy: A prospective clinical trial in primary brain tumor patients. Radiother Oncol. 2019 03; 132:27-33. Tringale KR, Nguyen T, Bahrami N, Marshall DC, Leyden KM, Karunamuni R, Seibert TM, Kay Gorman M, Connor M, Burkeen J, Piccioni DE, Farid N, Hattangadi-Gluth JA, McDonald CR. PMID: 30825966; PMCID: PMC6400307.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    57. Molecular classification of patients with grade II/III glioma using quantitative MRI characteristics. J Neurooncol. 2018 Sep; 139(3):633-642. Bahrami N, Hartman SJ, Chang YH, Delfanti R, White NS, Karunamuni R, Seibert TM, Dale AM, Hattangadi-Gluth JA, Piccioni D, Farid N, McDonald CR. PMID: 29860714; PMCID: PMC8120480.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    58. In Reply to Cihan. Int J Radiat Oncol Biol Phys. 2018 05 01; 101(1):235. Seibert TM, Hattangadi-Gluth JA. PMID: 29619968.
      View in: PubMed   Mentions:    Fields:    
    59. Relationship between kurtosis and bi-exponential characterization of high b-value diffusion-weighted imaging: application to prostate cancer. Acta Radiol. 2018 Dec; 59(12):1523-1529. Karunamuni RA, Kuperman J, Seibert TM, Schenker N, Rakow-Penner R, Sundar VS, Teruel JR, Goa PE, Karow DS, Dale AM, White NS. PMID: 29665707.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    60. Edge Contrast of the FLAIR Hyperintense Region Predicts Survival in Patients with High-Grade Gliomas following Treatment with Bevacizumab. AJNR Am J Neuroradiol. 2018 06; 39(6):1017-1024. Bahrami N, Piccioni D, Karunamuni R, Chang YH, White N, Delfanti R, Seibert TM, Hattangadi-Gluth JA, Dale A, Farid N, McDonald CR. PMID: 29622553; PMCID: PMC6002890.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    61. 4π plan optimization for cortical-sparing brain radiotherapy. Radiother Oncol. 2018 04; 127(1):128-135. Murzin VL, Woods K, Moiseenko V, Karunamuni R, Tringale KR, Seibert TM, Connor MJ, Simpson DR, Sheng K, Hattangadi-Gluth JA. PMID: 29519628; PMCID: PMC6084493.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    62. Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts. BMJ. 2018 01 10; 360:j5757. Seibert TM, Fan CC, Wang Y, Zuber V, Karunamuni R, Parsons JK, Eeles RA, Easton DF, Kote-Jarai Z, Al Olama AA, Garcia SB, Muir K, Grönberg H, Wiklund F, Aly M, Schleutker J, Sipeky C, Tammela TL, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, Røder MA, Iversen P, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokolorczyk D, Kluzniak W, Cannon-Albright L, Brenner H, Cuk K, Saum KU, Park JY, Sellers TA, Slavov C, Kaneva R, Mitev V, Batra J, Clements JA, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, Karow DS, Mills IG, Andreassen OA, Dale AM, PRACTICAL Consortium*. PMID: 29321194; PMCID: PMC5759091.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    63. Erratum to: Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status. J Neurooncol. 2017 12; 135(3):611. Delfanti RL, Piccioni DE, Handwerker J, Bahrami N, Krishnan A, Karunamuni R, Hattangadi-Gluth JA, Seibert TM, Srikant A, Jones KA, Snyder VS, Dale AM, White NS, McDonald CR, Farid N. PMID: 28905256.
      View in: PubMed   Mentions:    Fields:    
    64. Unilateral hippocampal wasting after combined-modality therapy for glioblastoma. Acta Oncol. 2018 05; 57(5):688-691. Seibert TM, Dalia Y, Karunamuni R, Piccioni D, McDonald CR, Farid N, Hattangadi-Gluth JA. PMID: 29125006; PMCID: PMC6086579.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    65. Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status. J Neurooncol. 2017 Dec; 135(3):601-609. Delfanti RL, Piccioni DE, Handwerker J, Bahrami N, Krishnan A, Karunamuni R, Hattangadi-Gluth JA, Seibert TM, Srikant A, Jones KA, Snyder VS, Dale AM, White NS, McDonald CR, Farid N. PMID: 28871469; PMCID: PMC5700844.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    66. Altered Network Topology in Patients with Primary Brain Tumors After Fractionated Radiotherapy. Brain Connect. 2017 06; 7(5):299-308. Bahrami N, Seibert TM, Karunamuni R, Bartsch H, Krishnan A, Farid N, Hattangadi-Gluth JA, McDonald CR. PMID: 28486817; PMCID: PMC5510052.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    67. Regional susceptibility to dose-dependent white matter damage after brain radiotherapy. Radiother Oncol. 2017 05; 123(2):209-217. Connor M, Karunamuni R, McDonald C, Seibert T, White N, Moiseenko V, Bartsch H, Farid N, Kuperman J, Krishnan A, Dale A, Hattangadi-Gluth JA. PMID: 28460824; PMCID: PMC5518466.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    68. Multi-component diffusion characterization of radiation-induced white matter damage. Med Phys. 2017 May; 44(5):1747-1754. Karunamuni RA, White NS, McDonald CR, Connor M, Pettersson N, Seibert TM, Kuperman J, Farid N, Moiseenko V, Dale AM, Hattangadi-Gluth JA. PMID: 28222217; PMCID: PMC5462441.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    69. Restriction Spectrum Imaging Improves Risk Stratification in Patients with Glioblastoma. AJNR Am J Neuroradiol. 2017 May; 38(5):882-889. Krishnan AP, Karunamuni R, Leyden KM, Seibert TM, Delfanti RL, Kuperman JM, Bartsch H, Elbe P, Srikant A, Dale AM, Kesari S, Piccioni DE, Hattangadi-Gluth JA, Farid N, McDonald CR, White NS. PMID: 28279985; PMCID: PMC5507368.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    70. Abnormalities in hippocampal volume of glioma patients prior to radiotherapy. Acta Oncol. 2017 Mar; 56(3):427-430. Karunamuni RA, Seibert TM, White NS, McEvoy L, Farid N, Brewer J, Dale AM, McDonald CR, Hattangadi-Gluth JA. PMID: 28156177; PMCID: PMC5426357.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    71. Cerebral Cortex Regions Selectively Vulnerable to Radiation Dose-Dependent Atrophy. Int J Radiat Oncol Biol Phys. 2017 04 01; 97(5):910-918. Seibert TM, Karunamuni R, Kaifi S, Burkeen J, Connor M, Krishnan AP, White NS, Farid N, Bartsch H, Murzin V, Nguyen TT, Moiseenko V, Brewer JB, McDonald CR, Dale AM, Hattangadi-Gluth JA. PMID: 28333012; PMCID: PMC5403140.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansPHPublic Health
    72. Radiation Dose-Dependent Hippocampal Atrophy Detected With Longitudinal Volumetric Magnetic Resonance Imaging. Int J Radiat Oncol Biol Phys. 2017 02 01; 97(2):263-269. Seibert TM, Karunamuni R, Bartsch H, Kaifi S, Krishnan AP, Dalia Y, Burkeen J, Murzin V, Moiseenko V, Kuperman J, White NS, Brewer JB, Farid N, McDonald CR, Hattangadi-Gluth JA. PMID: 28068234; PMCID: PMC5267344.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    73. Dose-dependent white matter damage after brain radiotherapy. Radiother Oncol. 2016 11; 121(2):209-216. Connor M, Karunamuni R, McDonald C, White N, Pettersson N, Moiseenko V, Seibert T, Marshall D, Cervino L, Bartsch H, Kuperman J, Murzin V, Krishnan A, Farid N, Dale A, Hattangadi-Gluth J. PMID: 27776747; PMCID: PMC5136508.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    74. Weight loss versus muscle loss: re-evaluating inclusion criteria for future cancer cachexia interventional trials. Support Care Cancer. 2017 02; 25(2):365-369. Roeland EJ, Ma JD, Nelson SH, Seibert T, Heavey S, Revta C, Gallivan A, Baracos VE. PMID: 27628947.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    75. Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI. J Magn Reson Imaging. 2017 02; 45(2):323-336. Brunsing RL, Schenker-Ahmed NM, White NS, Parsons JK, Kane C, Kuperman J, Bartsch H, Kader AK, Rakow-Penner R, Seibert TM, Margolis D, Raman SS, McDonald CR, Farid N, Kesari S, Hansel D, Shabaik A, Dale AM, Karow DS. PMID: 27527500; PMCID: PMC5222783.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    76. Distortion inherent to magnetic resonance imaging can lead to geometric miss in radiosurgery planning. Pract Radiat Oncol. 2016 Nov - Dec; 6(6):e319-e328. Seibert TM, White NS, Kim GY, Moiseenko V, McDonald CR, Farid N, Bartsch H, Kuperman J, Karunamuni R, Marshall D, Holland D, Sanghvi P, Simpson DR, Mundt AJ, Dale AM, Hattangadi-Gluth JA. PMID: 27523440; PMCID: PMC5099096.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    77. Restriction spectrum imaging predicts response to bevacizumab in patients with high-grade glioma. Neuro Oncol. 2016 11; 18(11):1579-1590. McDonald CR, Delfanti RL, Krishnan AP, Leyden KM, Hattangadi-Gluth JA, Seibert TM, Karunamuni R, Elbe P, Kuperman JM, Bartsch H, Piccioni DE, White NS, Dale AM, Farid N. PMID: 27106406; PMCID: PMC5063514.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    78. Gray Anatomy: The Case of the Missing "s". Int J Radiat Oncol Biol Phys. 2016 Mar 01; 94(3):435-7. Seibert TM, Mundt AJ. PMID: 26867871.
      View in: PubMed   Mentions:    Fields:    
    79. Radiation sparing of cerebral cortex in brain tumor patients using quantitative neuroimaging. Radiother Oncol. 2016 Jan; 118(1):29-34. Karunamuni RA, Moore KL, Seibert TM, Li N, White NS, Bartsch H, Carmona R, Marshall D, McDonald CR, Farid N, Krishnan A, Kuperman J, Mell LK, Brewer J, Dale AM, Moiseenko V, Hattangadi-Gluth JA. PMID: 26806266; PMCID: PMC4764402.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    80. Dose-Dependent Cortical Thinning After Partial Brain Irradiation in High-Grade Glioma. Int J Radiat Oncol Biol Phys. 2016 Feb 01; 94(2):297-304. Karunamuni R, Bartsch H, White NS, Moiseenko V, Carmona R, Marshall DC, Seibert TM, McDonald CR, Farid N, Krishnan A, Kuperman J, Mell L, Brewer JB, Dale AM, Hattangadi-Gluth JA. PMID: 26853338; PMCID: PMC4747044.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    81. Bevacizumab: radiation combination produces restricted diffusion on brain MRI. CNS Oncol. 2014; 3(5):329-35. Hesselink JR, Barkovich MJ, Seibert TM, Farid N, Muller KA, Murphy KT, Kesari S. PMID: 25363005; PMCID: PMC6113949.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    82. Interregional correlations in Parkinson disease and Parkinson-related dementia with resting functional MR imaging. Radiology. 2012 Apr; 263(1):226-34. Seibert TM, Murphy EA, Kaestner EJ, Brewer JB. PMID: 22371611; PMCID: PMC3309803.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    83. Stability of resting fMRI interregional correlations analyzed in subject-native space: a one-year longitudinal study in healthy adults and premanifest Huntington's disease. Neuroimage. 2012 Feb 01; 59(3):2452-63. Seibert TM, Majid DS, Aron AR, Corey-Bloom J, Brewer JB. PMID: 21945695; PMCID: PMC3254727.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    84. Default network correlations analyzed on native surfaces. J Neurosci Methods. 2011 Jun 15; 198(2):301-11. Seibert TM, Brewer JB. PMID: 21514321; PMCID: PMC3111080.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    85. Early parietal response in episodic retrieval revealed with MEG. Hum Brain Mapp. 2011 Feb; 32(2):171-81. Seibert TM, Hagler DJ, Brewer JB. PMID: 20623759; PMCID: PMC3107600.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    86. Parietal activity in episodic retrieval measured by fMRI and MEG. Neuroimage. 2011 Mar 15; 55(2):788-93. Seibert TM, Gimbel SI, Hagler DJ, Brewer JB. PMID: 21134473; PMCID: PMC3035726.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    87. Going their separate ways: dissociation of hippocampal and dorsolateral prefrontal activation during episodic retrieval and post-retrieval processing. J Cogn Neurosci. 2010 Mar; 22(3):513-25. Israel SL, Seibert TM, Black ML, Brewer JB. PMID: 19301994.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    88. Functional interactions between prefrontal and visual association cortex contribute to top-down modulation of visual processing. Cereb Cortex. 2007 Sep; 17 Suppl 1:i125-35. Gazzaley A, Rissman J, Cooney J, Rutman A, Seibert T, Clapp W, D'Esposito M. PMID: 17725995; PMCID: PMC4530799.
      View in: PubMed   Mentions: 137     Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    Tyler's Networks
    Concepts (211)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (73)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California